Pfizer Forecasts 2023 Sales of COVID Products Below Estimates

Reuters2023-01-31

(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lower demand in international markets and slower uptake of booster vaccines.

The U.S. drugmaker said it expects sales of $13.5 billion from the vaccine for 2023, below Refinitiv estimates of $14.39 billion, and projected $8 billion in sales of its antiviral pill, Paxlovid, short of $10.33 billion the Street expects.

The lower forecast casts uncertainty over the future of Pfizer's biggest selling products, which are expected to come under pressure this year as government spending on COVID vaccines and treatments declines.

The drugmaker has been hoping to offer its vaccine through the private market in the United States and other markets as government-backed vaccination campaigns for original shots near their end.

Pfizer stock slides 3.6% before the bell.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

SNeo
2023-02-01
SNeo
[Sweats]
supre
2023-01-31
supre
I'm so grateful to Mrs Teresa Fuller for making me believe online trading. I never thought any of this was real and I was so scared of losing my money.now I benefit alot from Teresa Fuller Platform on Facebook
valentia
2023-01-31
valentia
Tell me which counter will have growth sales?😆
druvaciam
2023-01-31
druvaciam
‌[难过] ‌

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2307719657?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-01-31 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2307719657","market":"us","top_or_hot":-1,"title":"Pfizer Forecasts 2023 Sales of COVID Products Below Estimates","media":"Reuters","content":"<html><head></head><body><p>(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lower demand in international markets and slower uptake of booster vaccines.</p><p>The U.S. drugmaker said it expects sales of $13.5 billion from the vaccine for 2023, below Refinitiv estimates of $14.39  billion, and projected $8 billion in sales of its antiviral pill, Paxlovid, short of $10.33 billion the Street expects.</p><p>The lower forecast casts uncertainty over the future of Pfizer&#39;s biggest selling products, which are expected to come under pressure this year as government spending on COVID vaccines and treatments declines.</p><p>The drugmaker has been hoping to offer its vaccine through the private market in the United States and other markets as government-backed vaccination campaigns for original shots near their end.</p><p>Pfizer stock slides 3.6% before the bell.<img src=\"https://static.tigerbbs.com/a02da077206a12e16d2836a290fb4727\" tg-width=\"829\" tg-height=\"671\" referrerpolicy=\"no-referrer\"/></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Forecasts 2023 Sales of COVID Products Below Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Forecasts 2023 Sales of COVID Products Below Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n2023-01-31 20:00 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lower demand in international markets and slower ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"2307719657","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2307719657","pubTimestamp":1675166450,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"辉瑞预测2023年COVID产品的销售额低于预期","themeId":"768868217a8a42b8834d60b34fc824ad","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lower demand in international markets and slower uptake of booster vaccines.The U.S. drugmaker said it expects sales of $13.5 billion from the vaccine for 2023, below Refinitiv estimates of $14.39  billion, and projected $8 billion in sales of its antiviral pill, Paxlovid, short of $10.33 billion the Street expects.The lower forecast casts uncertainty over the future of Pfizer's biggest selling products, which are expected to come under pressure this year as government spending on COVID vaccines and treatments declines.The drugmaker has been hoping to offer its vaccine through the private market in the United States and other markets as government-backed vaccination campaigns for original shots near their end.Pfizer stock slides 3.6% before the bell.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9955325580,"gmtCreate":1675224203340,"gmtModify":1676538984944,"author":{"id":"4112071922817752","authorId":"4112071922817752","name":"SNeo","avatar":"https://community-static.tradeup.com/news/d5b48d982c4246e1c1d0400e42ad5e32","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4112071922817752","authorIdStr":"4112071922817752"},"htmlText":"[Sweats]&nbsp;","listText":"[Sweats]&nbsp;","text":"[Sweats]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955325580","repostId":2307719657,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955943847,"gmtCreate":1675167462089,"gmtModify":1676538981040,"author":{"id":"4138270331761452","authorId":"4138270331761452","name":"supre","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4138270331761452","authorIdStr":"4138270331761452"},"htmlText":"I'm so grateful to Mrs Teresa Fuller for making me believe online trading. I never thought any of this was real and I was so scared of losing my money.now I benefit alot from Teresa Fuller Platform on Facebook","listText":"I'm so grateful to Mrs Teresa Fuller for making me believe online trading. I never thought any of this was real and I was so scared of losing my money.now I benefit alot from Teresa Fuller Platform on Facebook","text":"I'm so grateful to Mrs Teresa Fuller for making me believe online trading. I never thought any of this was real and I was so scared of losing my money.now I benefit alot from Teresa Fuller Platform on Facebook","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955943847","repostId":2307719657,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955949115,"gmtCreate":1675166857737,"gmtModify":1676538981000,"author":{"id":"4116569270341752","authorId":"4116569270341752","name":"valentia","avatar":"https://community-static.tradeup.com/news/64f8204fb4e5976eb0c1960943ccb2a2","vip":1,"crmLevel":4,"crmLevelSwitch":1,"idStr":"4116569270341752","authorIdStr":"4116569270341752"},"htmlText":"Tell me which counter will have growth sales?😆","listText":"Tell me which counter will have growth sales?😆","text":"Tell me which counter will have growth sales?😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955949115","repostId":2307719657,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9955940519,"gmtCreate":1675166565032,"gmtModify":1676538980984,"author":{"id":"4088707402306530","authorId":"4088707402306530","name":"druvaciam","avatar":"https://static.tigerbbs.com/5c3fb456a34258529f2ed7b7f945e0e8","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":6,"crmLevelSwitch":1,"idStr":"4088707402306530","authorIdStr":"4088707402306530"},"htmlText":"‌<a href=\"\">[难过]&nbsp;</a>‌","listText":"‌<a href=\"\">[难过]&nbsp;</a>‌","text":"‌[难过] ‌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955940519","repostId":2307719657,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":41,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2307719657"}